Which one is the real problem in the trifecta?
There's often no single real problem. Studies show POTS and EDS overlap often, but none shows one causing the other. For MCAS, a 2020 review found the link among all 3 unclear, and a 2026 paper's title states a lack of evidence for increased MCAS prevalence in POTS and/or hEDS. Our team tests to see which one is leading in you, and puts the most energy there first.
Why Do POTS, EDS and MCAS Show Up Together?
A 2026 systematic review concluded that EDS and POTS frequently co-occur, with proportions that depend on the population studied (Kwok, 2026). Most of the triad research is about hypermobile EDS (hEDS), the type diagnosed by exam, so that's the type this page means by EDS. The mast cell link has less behind it. A 2020 review of all 3 conditions found that "a real relationship between these entities is unclear due to a lack of scientific validity," and none of the papers it found came from searching the 3 together (Kucharik, 2020).
In 2026, 2 papers questioned the MCAS link in their titles. A research letter is titled "Lack of evidence for increased mast cell activation syndrome prevalence in postural orthostatic tachycardia syndrome and/or hypermobile Ehlers-Danlos syndrome" (Valdez, 2026), and a review of EDS and MCAS asks, "Is there scientific evidence?" (Cuenca-Gómez, 2026). Finding the 3 together says nothing yet about which one, if any, causes the others. POTS and EDS: why they show up together covers the proposed mechanisms.
How Do You Tell Which One Is the Real Problem?
In our team's experience, when you check everything, nearly anyone turns up something, and it's hard to know how much weight each finding deserves. Our team doesn't use fixed if-then rules to sort the 3. We ask what the boundary conditions are: which factors shape how you function the most, and whether solving them lets the system work better even while the other conditions are still there.
For each diagnosis, the question is whether it's causing the problem or contributing to it. In our team's view, the sorting rule follows from that: find the problem that, once solved, changes the course of the others, and put the most energy there first.
Is the Immune Side Leading?
In our team's view, a flare that hits the skin, throat and gut at the same time raises the question of whether something global, including the nervous system's control, is involved, while a reaction tied to one trigger suggests a more local cause. In our team's view, an allergist can test the mast cell side.
In our team's view, an allergist can test the mast cell side, and it helps to see whether your levels are actually abnormal before intervening.
Can an Infection Look Like POTS?
In our team's view, a gut infection such as SIBO or H. pylori may bring a racing heart and dizziness on standing that look a lot like POTS, because the body may step up blood flow to fight it off. A fever is the familiar version: your heart beats hard and fast, you sweat, and you're dizzy when you stand. If the autonomic problems are still there after the infection is treated, the cause may run the other way, and the autonomic side is the one to address.
In POTS, our team reads the high heart rate as a compensation that protects blood flow to the brain, so the heart rate alone can't say which side started it. What's left after one side is addressed can hint at which side was leading.
Where Does Hypermobility Fit In?
There's no blood test for hEDS, so the diagnosis rests on examining how a person moves. Our team also sees people who meet the flexibility criteria and feel fine, which is why we count hypermobility as a possible contributor before calling it the cause.
In our team's view, the people who check joint looseness and the people who judge muscle tone often work in different specialties, and the criteria lean toward the hypermobility model. Our team checks whether low muscle tone comes with the flexibility, as covered in hypermobile EDS treatment: rule out low tone first.
How Are POTS, EDS and MCAS Treated Together?
There's no single treatment for all 3. In our team's view, an allergist can test the mast cell side (see how MCAS and POTS are treated when both are present). Our team's work is on the autonomic side: testing how the brain regulates heart rate, blood pressure and brain blood flow. We don't treat connective tissue or joint laxity. For one person with both, see one patient's EDS and POTS case.
See how our team tests upright regulation in 3D
Watch brain blood flow and heart rate respond as you go from lying down to upright.
Take the 3D TourSeveral diagnoses and dizzy when you stand? See how the clinic evaluates dysautonomia.
See dysautonomia carePOTS, EDS and MCAS: FAQ
What is the POTS, EDS and MCAS trifecta?
It's the name for POTS, Ehlers-Danlos syndrome and mast cell activation syndrome turning up in the same person. EDS and POTS frequently co-occur (Kwok, 2026), but a 2020 review couldn't establish a link among all 3 (Kucharik, 2020).
Does having EDS mean you have MCAS?
Having EDS doesn't mean you have MCAS. A 2026 research letter's title states a lack of evidence for increased MCAS prevalence in POTS and/or hypermobile EDS (Valdez, 2026), and a 2026 review asks in its title whether there's scientific evidence for an EDS and MCAS link (Cuenca-Gómez, 2026). In our team's view, it helps to know from lab work whether your levels are abnormal before trying to calm the immune system down.
How do you treat POTS, EDS and MCAS together?
There's no single treatment for all 3. In our team's view, you test first to see which one is leading in you, and put the most energy there.
Who checks each part of the trifecta?
In our team's view, an allergist can test the mast cell side, hEDS is diagnosed by physical exam because there's no blood test for it, and our team tests the autonomic side: how the brain regulates heart rate, blood pressure and brain blood flow.
Can the hypermobility be changed?
Our team doesn't treat connective tissue or joint laxity. What we test is whether low muscle tone comes with the flexibility, which is covered in hypermobile EDS treatment.
Sources
- Kwok CS, Hagger G, Gillespie D, et al. The co-existence of Ehlers-Danlos syndrome and postural orthostatic tachycardia syndrome: A systematic review of the literature. Autonomic Neuroscience. 2026;267:103453. doi:10.1016/j.autneu.2026.103453
- Kucharik AH, Chang C. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS). Clinical Reviews in Allergy & Immunology. 2020;58(3):273-297. doi:10.1007/s12016-019-08755-8
- Valdez JA, Gansert E, Bhuiyan FJ, et al. Lack of evidence for increased mast cell activation syndrome prevalence in postural orthostatic tachycardia syndrome and/or hypermobile Ehlers-Danlos syndrome. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(11):2728-2730.e1. doi:10.1016/j.jaip.2026.08.005
- Cuenca-Gómez JA, Dawid-Milner MS, Sánchez-Martínez R. Association between Ehlers-Danlos syndrome and mast cell activation syndrome: Is there scientific evidence? Revista Clínica Española (English Edition). 2026;226(2):502457. doi:10.1016/j.rceng.2026.502457